Skip to main content
Erschienen in: World Journal of Urology 12/2018

28.05.2018 | Original Article

CATCH-22: a manual bladder washout protocol to improve care for clot retention

verfasst von: Emma Clarebrough, Shannon McGrath, Daniel Christidis, Nathan Lawrentschuk

Erschienen in: World Journal of Urology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To review current practices in manual bladder washouts (MBW) for haematuria with clot retention, comparing those conducted by a urology unit to other inpatient services. Secondly, to describe a standardised protocol for MBWs.

Methods

Prospective data were collected for patients treated for clot retention, from initial management by referral units through to implementation of a standardised MBW by the urology service. Outcomes measured included re-catheterisation, MBW volumes, clot evacuated and time to discharge or subsequent intervention.

Results

Initial catheters inserted by referral teams were sized 16 Fr–20 Fr, all except one requiring upsizing. Mean washout volumes of 145 ml (SD 125) and 5392 ml (SD 847) were used by referring units and the urology service, respectively. Mean volume of clot evacuated by the standardised MBW was 617 ml (SD 313). Continuous bladder irrigation (CBI) was commenced in 16 patients (66%) prior to referral to urology. Median time to discharge was 48 h.

Conclusion

Initial catheter insertion is of inadequate size, as is the volume of washout performed. Referring services fail to clear adequate amounts of clot with washouts posing potential risks to patients. The standard management of clot retention should involve the use of at least a 22 F catheter, implement best practice infection control and adopt the last Clot + 1L rule with catheter manipulation. The key points of our recommended MBW are summarised with the acronym CATCH-22. This protocol can guide initial management of clot retention and be used as an educational tool.
Literatur
1.
Zurück zum Zitat Scholtes S (2002) Management of clot retention following urological surgery. Nurs Times 98(28):48–49PubMed Scholtes S (2002) Management of clot retention following urological surgery. Nurs Times 98(28):48–49PubMed
2.
Zurück zum Zitat Plowman RP, Graves N, Roberts JA (1997) Hospital acquired infection. Office of Health Economics, London Plowman RP, Graves N, Roberts JA (1997) Hospital acquired infection. Office of Health Economics, London
3.
Zurück zum Zitat Tambyah PA, Knasinski V, Maki DG (2002) The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 23(1):27–31CrossRefPubMed Tambyah PA, Knasinski V, Maki DG (2002) The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 23(1):27–31CrossRefPubMed
4.
Zurück zum Zitat Royal Australasian College of Surgeons (2011) Case Note Review Booklet. Case 13: Clot retention can lead to death, 3rd edn. RACS, Melbourne Royal Australasian College of Surgeons (2011) Case Note Review Booklet. Case 13: Clot retention can lead to death, 3rd edn. RACS, Melbourne
5.
Zurück zum Zitat Dungerwalla M et al (2015) Manual bladder washouts for urinary clot retention: a survey of knowledge among healthcare workers. Can J Urol 22(6):8093–8098PubMed Dungerwalla M et al (2015) Manual bladder washouts for urinary clot retention: a survey of knowledge among healthcare workers. Can J Urol 22(6):8093–8098PubMed
6.
Zurück zum Zitat Hanno P, Malkowicz S, Wein A (2007) Urological emergencies. Penn clinical manual of urology. Saunders, Philadelphia Hanno P, Malkowicz S, Wein A (2007) Urological emergencies. Penn clinical manual of urology. Saunders, Philadelphia
7.
Zurück zum Zitat ACI Urology Network Bladder Irrigation Guidelines. NSW ACI Urology Network Bladder Irrigation Guidelines. NSW
8.
Zurück zum Zitat Ritch CR, Ordonez MA, Okhunov Z et al (2009) Pilot study of alteplase (tissue plasminogen activator) for treatment of urinary clot retention in an in vitro model. J Endourol 23(8):1353–1357CrossRefPubMed Ritch CR, Ordonez MA, Okhunov Z et al (2009) Pilot study of alteplase (tissue plasminogen activator) for treatment of urinary clot retention in an in vitro model. J Endourol 23(8):1353–1357CrossRefPubMed
9.
Zurück zum Zitat Bolger R, Webb C (2012) Clinical guideline: performance of a manual bladder washout. Austin Health, Melbourne Bolger R, Webb C (2012) Clinical guideline: performance of a manual bladder washout. Austin Health, Melbourne
10.
Zurück zum Zitat Warlick C, Mouli S, Allaf M, Wagner A, Kavoussi L (2006) Bladder irrigation using hydrogen peroxide for clot evacuation. Urology 68(6):1331–1332CrossRefPubMed Warlick C, Mouli S, Allaf M, Wagner A, Kavoussi L (2006) Bladder irrigation using hydrogen peroxide for clot evacuation. Urology 68(6):1331–1332CrossRefPubMed
11.
Zurück zum Zitat Ritch CR, Ordonez MA, Okhunov Z et al (2009) Pilot study of alteplase (tissue plasminogen activator) for treatment of urinary clot retention in an in vitro model. J Endourol 23(8):1353–1357CrossRefPubMed Ritch CR, Ordonez MA, Okhunov Z et al (2009) Pilot study of alteplase (tissue plasminogen activator) for treatment of urinary clot retention in an in vitro model. J Endourol 23(8):1353–1357CrossRefPubMed
12.
Zurück zum Zitat DeWilde S, Carey IM, Emmas C, Richards N, Cook DG (2006) Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 92:1064–1070CrossRefPubMed DeWilde S, Carey IM, Emmas C, Richards N, Cook DG (2006) Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 92:1064–1070CrossRefPubMed
13.
Zurück zum Zitat Wysowski DK, Nourjah P, Swartz L (2007) Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167:1414–1419CrossRefPubMed Wysowski DK, Nourjah P, Swartz L (2007) Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167:1414–1419CrossRefPubMed
14.
Zurück zum Zitat Ostini R, Hegney D, Mackson JM, Williamson M, Tett SE (2008) Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiol Drug Saf 17:1077–1090CrossRefPubMed Ostini R, Hegney D, Mackson JM, Williamson M, Tett SE (2008) Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiol Drug Saf 17:1077–1090CrossRefPubMed
15.
Zurück zum Zitat Van Savage JG, Fried F (1995) Anticoagulant associated hematuria: a prospective study. J Urol 153:1594–1596CrossRefPubMed Van Savage JG, Fried F (1995) Anticoagulant associated hematuria: a prospective study. J Urol 153:1594–1596CrossRefPubMed
16.
Zurück zum Zitat Avidor Y, Nadu A, Matzkin H (2000) Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology 55:22–24CrossRefPubMed Avidor Y, Nadu A, Matzkin H (2000) Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology 55:22–24CrossRefPubMed
17.
Zurück zum Zitat Mosley DH, Schatz IJ, Breneman GM, Keyes JW (1963) Long-term anticoagulant therapy. Complications and control in a review of 978 cases. JAMA 186:914–916CrossRefPubMed Mosley DH, Schatz IJ, Breneman GM, Keyes JW (1963) Long-term anticoagulant therapy. Complications and control in a review of 978 cases. JAMA 186:914–916CrossRefPubMed
18.
Zurück zum Zitat Satasivam P, Reeves F, Lin M, Daruwalla J, Casan J, Lim C, Royce PL (2012) The effect of oral anticoagulation on the prevalence and management of haematuria in a contemporary Australian patient cohort. BJU Int 110:80–84CrossRefPubMed Satasivam P, Reeves F, Lin M, Daruwalla J, Casan J, Lim C, Royce PL (2012) The effect of oral anticoagulation on the prevalence and management of haematuria in a contemporary Australian patient cohort. BJU Int 110:80–84CrossRefPubMed
19.
Zurück zum Zitat Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA et al (2007) Estimating health care-associated infections and deaths in US hospitals. Public Health Rep 122(2):160–166CrossRefPubMedPubMedCentral Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA et al (2007) Estimating health care-associated infections and deaths in US hospitals. Public Health Rep 122(2):160–166CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat National Audit Office (2009) Reducing healthcare associated infections in hospitals in England. London Stationery Office. NAO, London National Audit Office (2009) Reducing healthcare associated infections in hospitals in England. London Stationery Office. NAO, London
Metadaten
Titel
CATCH-22: a manual bladder washout protocol to improve care for clot retention
verfasst von
Emma Clarebrough
Shannon McGrath
Daniel Christidis
Nathan Lawrentschuk
Publikationsdatum
28.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2346-z

Weitere Artikel der Ausgabe 12/2018

World Journal of Urology 12/2018 Zur Ausgabe

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Männern mit Zystitis Schmalband-Antibiotika verordnen

03.05.2024 Zystitis Nachrichten

Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.